Locke Bio
PrivateLast Round
Seed
Mar 1, 2020
Total Funding Raised
$85,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Locke Bio operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Seed round in March 2020.
Locke Bio is a digital health platform company that provides a white-labeled, integrated infrastructure for enterprises to launch direct-to-consumer telehealth and pharmacy services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, E-commerce, Digital Payments, Pharma Supply Chain, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Payment Processing Fee, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Locke Bio Comparables
Compare Locke Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beluga Health | 88% | |
| Rimo Health | 86% | |
| Bask Health | 86% |
For institutional investors. Book with your work email.
Locke Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Locke Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Empros Capital | Seed |
| IKJ Capital | Seed |
| 10X Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 56% MoM.
- Apr 15, 2026
Monthly visitors grew 104% MoM, reaching 4.9K.
For institutional investors. Book with your work email.
Locke Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Locke Bio's valuation, stock price, and market status.
Is Locke Bio a public or private company?
Locke Bio is a private company.
What is the current stock price of Locke Bio?
Locke Bio is a private company, so its shares have no public market price. Caplight tracks Locke Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Locke Bio worth (valuation)?
Valuation information for Locke Bio is not publicly available.
Can I buy Locke Bio stock?
Locke Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Locke Bio's last funding round?
Locke Bio's most recent funding round was Seed on March 1, 2020.
Who are the main investors in Locke Bio?
Key investors in Locke Bio include Empros Capital, IKJ Capital, 10X Capital.
Will Locke Bio IPO soon?
No public IPO plans have been announced for Locke Bio.
How can I track Locke Bio secondary market activity?
Caplight tracks bids, offers, and trades in Locke Bio's shares on secondary markets.